| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/27/2008 | US7378080 Detection, measurement, calibration gene expression |
| 05/27/2008 | US7378078 Chimeric polypeptide comprising bioluminescent/chemiluminescent, kinase and/or silencing domains for monitoring efficacy of therapeutic agents |
| 05/27/2008 | CA2438170C Modulated release particles for aerosol delivery |
| 05/27/2008 | CA2413629C Solid method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 05/27/2008 | CA2272063C Antithrombotic organic nitrates |
| 05/27/2008 | CA2264895C Device and method for treating ophthalmic diseases |
| 05/27/2008 | CA2258494C Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 05/27/2008 | CA2145641C Pseudo-adenovirus vectors |
| 05/27/2008 | CA2120358C Hormone analogs with multiple ctp extensions |
| 05/27/2008 | CA2117181C Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 05/22/2008 | WO2008061192A2 Stabilized maml peptides and uses thereof |
| 05/22/2008 | WO2008061014A2 Self-assembling peptide amphiphiles for tissue engineering |
| 05/22/2008 | WO2008060622A2 Improved methods and compositions for wound healing |
| 05/22/2008 | WO2008060610A2 Systemic administration of colony stimulating factors to treat amyloid associated disorders |
| 05/22/2008 | WO2008060552A2 Synthetic peptide amides and dimers thereof |
| 05/22/2008 | WO2008060481A1 Method for treating chronic pain |
| 05/22/2008 | WO2008060357A2 Methods of polypeptide production |
| 05/22/2008 | WO2008060240A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2 |
| 05/22/2008 | WO2008060219A1 Il- 18 vaccine for the treatment of various inflammatory conditions. |
| 05/22/2008 | WO2008059927A1 Collagen peptide composition and food or beverage containing the same |
| 05/22/2008 | WO2008059917A1 Thrombin mutant |
| 05/22/2008 | WO2008059877A1 Aptamer against midkine and use thereof |
| 05/22/2008 | WO2008059798A1 Method for detecting predisposition to infertility or pregnant state of mammal, method for controlling pregnancy or birth and method for preventing or treating immune-mediated disease |
| 05/22/2008 | WO2008059225A1 Treatment of ectoparasitic infestation |
| 05/22/2008 | WO2008059222A2 Animal feeds and veterinary compositions |
| 05/22/2008 | WO2008059127A1 Peptide-containing pharmaceutical and/or cosmetic composition |
| 05/22/2008 | WO2008059066A1 New chemokine derivatives of ccl14, synthesis and use as drugs for the treatment of allergic diseases |
| 05/22/2008 | WO2008059062A1 Colonic delivery using zn/pectin beads with a eudragit coating. |
| 05/22/2008 | WO2008059043A2 Combination of coagulation factor viii with apc-resistant factor v |
| 05/22/2008 | WO2008059041A2 Complementation of factor xi deficiency by factor v mutants |
| 05/22/2008 | WO2008059009A2 Factor v mutants for hemostasis in hemophilia |
| 05/22/2008 | WO2008058942A2 Method of cell culture and method of treatment comprising a vepo protein variant |
| 05/22/2008 | WO2008058728A1 Compositions and methods for immunotherapy |
| 05/22/2008 | WO2008058679A2 Novel amides acting on the adenosine receptors |
| 05/22/2008 | WO2008058547A2 Alpha-lactalbumin composition |
| 05/22/2008 | WO2008058461A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 05/22/2008 | WO2008058393A1 Thiophene analogues for the treatment or prevention of flavivirus infections |
| 05/22/2008 | WO2008039843A3 Novel peptides that promote lipid efflux |
| 05/22/2008 | WO2008037497A3 Galectin-2 for the treatment of inflammatory diseases of the skin |
| 05/22/2008 | WO2008035001A3 Composition for the treatment of amyotrophic lateral sclerosis |
| 05/22/2008 | WO2008027687A3 Use of tenecteplase for treating acute ischemic stroke |
| 05/22/2008 | WO2008027000A3 Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health |
| 05/22/2008 | WO2008026999A3 Candidates against infection |
| 05/22/2008 | WO2008024919A9 Interferon antagonists, antibodies thereto, and associated methods of use |
| 05/22/2008 | WO2008021550A3 Thiol-based agents for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 05/22/2008 | WO2008015023A3 Use of photomedin products for preventing and/or treating neuronal dysfunctions |
| 05/22/2008 | WO2008012476A3 Use of carboxypeptidases in the cosmetics and therapeutic field |
| 05/22/2008 | WO2007141344B1 Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic |
| 05/22/2008 | WO2007126439A3 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r |
| 05/22/2008 | WO2007122388A3 Nanoparticles containing three various ligands for providing immune responses against infectious agents |
| 05/22/2008 | WO2006124412A3 Methods for the rapid expansion of antigen specific t-cells |
| 05/22/2008 | WO2006059913A9 Modulation of ovulation |
| 05/22/2008 | US20080120734 Compositions and methods for regulated protein expression in gut |
| 05/22/2008 | US20080119819 Use of Growth Hormone in Treatment of Long-Bone Fractures |
| 05/22/2008 | US20080119636 Methods and materials for cancer treatment |
| 05/22/2008 | US20080119569 Polymer-based sustained release device |
| 05/22/2008 | US20080119562 Methods of Inducing Terminal Differentiation |
| 05/22/2008 | US20080119542 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 05/22/2008 | US20080119423 isolated antisense oligonucleotide hybrids for treating pain in a mammal; biodrugs |
| 05/22/2008 | US20080119412 Polypeptides for Modulating Binding of Trp Channel Proteins and Trp- Associated Proteins |
| 05/22/2008 | US20080119411 use of salmon calcitonin in combination with PTH for the oral administration of PTH for the treatment of osteoporosis without the potentially toxic hypercalcemic side effects |
| 05/22/2008 | US20080119410 comprising administering bactericidal/permeability-increasing protein (BPI proteins) or fragments to a patient suffering from age related macular degeneration (ARMD) |
| 05/22/2008 | US20080119409 Method for the production of conjugates of insulin-like growth factor-1 and poly(ethylene glycol) |
| 05/22/2008 | US20080119408 Pth formulations for intranasal delivery |
| 05/22/2008 | US20080119407 Vitamin D Receptor Modulators |
| 05/22/2008 | US20080119406 caltrin or functionally active peptide fragment together with a pharmaceutically acceptable carrier; osteroporosis, osteoarthritis, Paget's disease, osteomalacia, prolonged bed rest, chronic disuse of a limb, anorexia, microgravity, exogenous and endogenous gonadal insufficiency, bone fracture |
| 05/22/2008 | US20080119405 Fowlicidins and Methods of Their Use |
| 05/22/2008 | US20080119404 angiopoietin-related growth factor used as antiobesity agent, an antidiabetic agent, and/or a hypolipidemic agent; polypeptides |
| 05/22/2008 | US20080119403 Haparin-Binding Protein Modified with Heparan Sulfate Sugar Chains, Process for Producing the Same and Pharmaceutical Compositions Containing the Same |
| 05/22/2008 | US20080119402 Compositions and methods for the inhibition of dishevelled proteins |
| 05/22/2008 | US20080119401 A polypeptide produced by the parathyroid glands using such analogues alone or in combination with a bisphosphonate or calcitonin to treat osteoporosis |
| 05/22/2008 | US20080119400 Regulators of complement activation (RCA); diagnosis/therapy of complement system for autoimmune disease treatment; open reading frames; point mutations; membrane cofactor/decay accelerating factor/factor H |
| 05/22/2008 | US20080119399 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent |
| 05/22/2008 | US20080119398 Modified Thioredoxin |
| 05/22/2008 | US20080119397 Kahalalide Compositions |
| 05/22/2008 | US20080119396 TGF analogs/promoter that bind to and neutralize cystine knot-containing BMP antagonists such as the CAN subfamily of Cystine-knot proteins including sclerostin and promotes bone growth and mineralization in vivo; |
| 05/22/2008 | US20080119395 Novel Depsipeptides and Process for Preparing Same |
| 05/22/2008 | US20080119394 folliculogenesis and follicular maturation without ovarian hyperstimulation; compositions that contain various amounts of FSH and hCG, as well as various FSH-to-hCG ratios, supplied in a single preparation; enable the practitioner to optimize ovulatory stimulation in flexible manner |
| 05/22/2008 | US20080119393 Novel exendin agonist compounds |
| 05/22/2008 | US20080119392 Methods and devices for administration of substances into the intradermal layer of skin for systemic absorption |
| 05/22/2008 | US20080119391 Comprising hydrolyzed gelatin/tryptophan and ingestible carrier; for decubitus ulcers/bariatric surgery |
| 05/22/2008 | US20080119390 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 05/22/2008 | US20080119389 EGCG, a protein hydrolysate and Coenzyme Q-10; orEGCG, a protein hydrolysate and resveratrol; orEGCG, a protein hydrolysate, ligustilide or other phthalides or herbal extracts containing ligustilide or other phthalides, and Coenzyme Q-10; antidiabetic agent ( insulin or non-insulin dependent diabetes) |
| 05/22/2008 | US20080119388 METHODS OF USING sIP-10 TO ASSESS HCV CLEARANCE AND/OR RESPONSE TO INTERFERON THERAPY |
| 05/22/2008 | US20080119387 Contacting small molecule or polypeptide with a cell, cell extract, or purified cell components containing L41 and ribosomes, detecting whether the test composition inhibits the interaction of L41 with the ribosomes; anddetermining whether the test composition inhibits peptidyl transferase activity |
| 05/22/2008 | US20080119386 Nutritional formula for athletes' recovery |
| 05/22/2008 | US20080119385 Modified two-component gelation systems, methods of use and methods of manufacture |
| 05/22/2008 | US20080119384 Use of TPO peptide compounds and pharmaceutical compostions in the treatment of anemia |
| 05/22/2008 | US20080118991 Method for isolating and purifying grass pollen allergens |
| 05/22/2008 | US20080118947 Isolating connective tissue protein from porcine bone tissue via pepsin digestion, salt fractionation and ethanol extraction |
| 05/22/2008 | US20080118945 Use of gelsolin to treat infections |
| 05/22/2008 | US20080118933 Methods of screening for inhibitors of antiplasmin cleaving enzyme |
| 05/22/2008 | US20080118592 treating pruritis associated with psychosis by local administration; skin itching, hallucinations obsessive compulsive disorders treated by low dose, intramuscular administration of botulinum toxin |
| 05/22/2008 | US20080118553 Tannate salt form of polypeptide mixtures, their preparation and use |
| 05/22/2008 | US20080118545 Sustained-Release Composition, Process for Producing the Same and Use of the Same |
| 05/22/2008 | US20080118542 Growth Factor Composition |
| 05/22/2008 | US20080118536 A carrier and a grass allergen purified by a combination of hydrophobic interaction chromatography, gel filtration and cation exchange chromatography; antiallergens; improved diagnosis of pollen allergies |
| 05/22/2008 | US20080118534 Low dose, intramuscular injection of botulinum toxin |
| 05/22/2008 | US20080118533 Treatment of chronic chalazion and hordeolum with botulinum toxin |
| 05/22/2008 | US20080118529 Improves immunogenicity of vaccines for cancer, immunocastration, autoimmune diseases, atherosclerosis, amyloidoses, graft-versus-host rejections and transplant rejections |